Advances in Viral Vector-Based TRAIL Gene Therapy for Cancer.
about
Survivin-targeting Artificial MicroRNAs Mediated by Adenovirus Suppress Tumor Activity in Cancer Cells and Xenograft ModelsCombined therapy with oncolytic adenoviruses encoding TRAIL and IL-12 genes markedly suppressed human hepatocellular carcinoma both in vitro and in an orthotopic transplanted mouse model.TRAIL-mediated signaling in prostate, bladder and renal cancer.PSMA-specific theranostic nanoplex for combination of TRAIL gene and 5-FC prodrug therapy of prostate cancer.Efficacy of combining ING4 and TRAIL genes in cancer-targeting gene virotherapy strategy: First evidence in preclinical hepatocellular carcinoma.Targeted nonviral gene therapy in prostate cancer
P2860
Advances in Viral Vector-Based TRAIL Gene Therapy for Cancer.
description
2011 nî lūn-bûn
@nan
2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Advances in Viral Vector-Based TRAIL Gene Therapy for Cancer.
@ast
Advances in Viral Vector-Based TRAIL Gene Therapy for Cancer.
@en
Advances in Viral Vector-Based TRAIL Gene Therapy for Cancer.
@nl
type
label
Advances in Viral Vector-Based TRAIL Gene Therapy for Cancer.
@ast
Advances in Viral Vector-Based TRAIL Gene Therapy for Cancer.
@en
Advances in Viral Vector-Based TRAIL Gene Therapy for Cancer.
@nl
prefLabel
Advances in Viral Vector-Based TRAIL Gene Therapy for Cancer.
@ast
Advances in Viral Vector-Based TRAIL Gene Therapy for Cancer.
@en
Advances in Viral Vector-Based TRAIL Gene Therapy for Cancer.
@nl
P2093
P2860
P356
P1433
P1476
Advances in Viral Vector-Based TRAIL Gene Therapy for Cancer.
@en
P2093
Britnie R James
Lyse A Norian
Thomas S Griffith
P2860
P304
P356
10.3390/CANCERS3010603
P577
2011-02-10T00:00:00Z